ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0A8E Xeris Biopharma Inc

0.00
0.00 (0.00%)
Last Updated: -
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 202120222023
USD ($)USD ($)USD ($)
Total Revenue 49.59M110.25M163.91M
Operating Income -115.16M-81.94M-44.01M
Pre Tax Income -122.73M-96.08M-63.5M
Net Income -122.73M-94.66M-62.26M
Preferred Dividends 000
Basic Earnings Per Share (EPS) -0.983-0.695-0.451
EBIT -115.16M-85.1M-38.81M
EBITDA -113.28M-69.7M-31.68M

Your Recent History

Delayed Upgrade Clock